Vivos Therapeutics is a medical technology company focused on the development and commercialization of a suite of diagnostic and treatment modalities for patients with cranial and/or dentofacial abnormalities and the array of medical conditions that may result from them, including mild to moderate obstructive sleep apnea and snoring in adults. Co. calls its solution The Vivos Method. The Vivos Method is a therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by Co. and prescribed by trained dentists in cooperation with their medical colleagues. The VVOS average annual return since 2020 is shown above.
The Average Annual Return on the VVOS average annual return since 2020 page and across the coverage universe of our site,
is a measure of the annualized return over the past ten years (or specified start date) for a given investment
(up to the end of prior trading session recorded). Arguably, choosing ten years for a measurement
period is on the one hand completely arbitrary, but on the other hand provides a sufficiently long window
to capture long-term trends.
Thus, researching Average Annual Returns is good practice for investors — whether VVOS average annual return since 2020 or other benchmarks/peers
— and when doing so it is also important to factor in dividends, because a financial instrument's annualized return is
more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors
by performing the VVOS average annual return calculation with any dividends reinvested as applicable (on ex-dates).
|